On September 15, 2023, Anson Group delivered a letter to MEI Pharma, Inc. nominating a slate of 3 candidates, including Taheer Datoo, Mark Feldberg, and James Flynn, for election at the Company?s 2024 annual meeting of stockholders. Anson Group stated that while it remains open to reaching a resolution with the Company and may engage in communications with members of the management team and Board in furtherance thereof, Anson Group expressed its view that the change at the Company is urgently required and that there exists a valid basis for removing the existing Board members for cause.